Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation

Journal of Cancer Survivorship

Volumn 10, Issue 4, 2016, Pages 663-673

  Fardell, Joanna E ^a,b   Thewes, Belinda ^a,f   Turner, Jane ^c   Gilchrist, Jemma ^d   Sharpe, Louise ^a   Smith, Allan Ben ^a   Girgis, Afaf ^e   Butow, Phyllis ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acceptance and Commitment Therapy; Cancer; Fear of cancer recurrence; Metacognitive Therapy; Oncology; Survivorship

Indexed keywords

COGNITION; FEAR; HUMAN; PHOBIA; PSYCHOLOGY; SURVIVOR; TUMOR RECURRENCE;

COGNITION; FEAR; HUMANS; NEOPLASM RECURRENCE, LOCAL; PHOBIC DISORDERS; SURVIVORS;

EID: 84954531172     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-015-0512-5     Document Type: Review

References (70)

1. Cella DF, Mahon SM, Donovan MI. Cancer recurrence as a traumatic event. Behav Med. 1990;16:15–22.
2. Halldórsdóttir S, Hamrin E. Experiencing existential changes: the lived experience of having cancer. Cancer Nurs. 1996;19:29–36.
3. Lagerdahl ASK, Moynihan M, Stollery B. An exploration of the existential experiences of patients following curative treatment for cancer: reflections from a UK sample. J Psychosoc Oncol. 2014;32(5):555–75.
4. Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17:241–51.
5. Kim Y, Carver CS, Spillers RL, et al. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2012;21:517–25.
6. Mellon S, Kershaw TS, Northouse LL, Freeman-Gibb L. A family-based model to predict fear of recurrence for cancer survivors and their caregivers. Psycho-Oncology. 2007;16:214–23.
7. Simard S, Savard J. Screening and psychiatric comorbidity of clinical fear of cancer recurrence. 4th Canadian breast cancer research alliance reasons for hope scientific conference. Vancouver, Canada. 2008.
8. Thewes B, Butow P, Bell ML, et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours. Support Care Cancer. 2012;20:2651–9.
9. Hodges L, Humphris G. Fear of recurrence and psychological distress in head and neck cancer patients and their carers. Psycho-Oncology. 2009;18:841–8.
10. Hart S, Latini D, Cowan J, et al. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16:161–9.
11. Lebel S, Tomei C, Feldstain A, et al. Does fear of cancer recurrence predict cancer survivors’ health care use? Support Care Cancer. 2013;21:901–6.
12. Llewellyn C, Weinman J, McGurk M, Humphris GM. Can we predict which head and neck cancer survivors develop fears of cancer recurrence? J Psychosom Res. 2008;65:525–32.
13. Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:1273–80.
14. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (>5 years) cancer survivors—a systematic review of quantitative studies. Psycho-Oncology. 2013;22:1–11.
15. Hodgkinson K. What is the psychosocial impact of cancer? In: Hodgkinson K, Gilchrist J, editors. Psychosocial care of cancer patients: a health professionals guide to what to say and do. Melbourne: Ausmed Publications; 2008.
16. Armes J, Crowe M, Colbourne L, et al. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9.
17. van den Beuken-van Everdingen MHJ, Peters ML, de Rijke JM, et al. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psycho-Oncology. 2008;17:1137–45.
18. Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psycho-Oncology. 2013;22:978–86.
19. Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Survivorship. 2013;7:300–22.
20. Lee-Jones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psycho-Oncology. 1997;6:95–105.
21. Witte K. Putting the fear back into fear appeals: the extended parallel process model. Commun Monogr. 1992;59:329–49.
22. McGinty HL, Goldenberg JL, Jacobsen PB. Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psycho-Oncology. 2012;21:203–10.
23. Rippetoe PA, Rogers RW. Effects of components of protection-motivation theory on adaptive and maladaptive coping with a health threat. J Pers Soc Psychol. 1987;52:596–604.
24. Corter AL, Findlay M, Broom R, et al. Beliefs about medicine and illness are associated with fear of cancer recurrence in women taking adjuvant endocrine therapy for breast cancer. Br J Health Psychol. 2013;18:168–81.
25. Park CL, Cho D, Blank TO, Wortmann JH. Cognitive and emotional aspects of fear of recurrence: predictors and relations with adjustment in young to middle-aged cancer survivors. Psycho-Oncology. 2013;22:1630–8.
26. Phillips KM, McGinty HL, Gonzalez BD, et al. Factors associated with breast cancer worry 3 years after completion of adjuvant treatment. Psycho-Oncology. 2013;22:936–9.
27. Easterling DV, Leventhal H. Contributions of concrete cognition to emotion: neutral symptoms as elicitors of worry about cancer. J Appl Psychol. 1989;74:787–96.
28. Hilton BA. The relationship of uncertainty, control, commitment, and threat of recurrence to coping strategies used by women diagnosed with breast cancer. J Behav Med. 1989;12:39–54.
29. Liu Y, Pérez M, Schootman M, et al. Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat. 2011;130:165–73.
30. Mishel MH. Uncertainty in chronic illness. Annu Rev Nurs Res. 1999;17:269–94.
31. Lebel S, Maheu C, Lefebvre M, et al. Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Survivorship. 2014;8:485–96.
32. Mishel MH, Germino BB, Gil KM, et al. Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors. Psycho-Oncology. 2005;14:962–78.
33. Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25:555–62.
34. Eisenberg SA, Kurita K, Taylor-Ford M, et al. Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psycho-Oncology. 2015;24:228–35.
35. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16:143–63.
36. Sharpe L, Curran L. Understanding the process of adjustment to illness. Soc Sci Med. 2006;62:1153–66.
37. Rabin C, Leventhal H, Goodin S. Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients. Health Psychol. 2004;23:407–12.
38. Koch L, Bertram H, Eberle A, et al. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship—a multi-regional population-based study. Psycho-Oncology. 2014;23:547–54.
39. Lipkus IM, Klein WMP, Skinner CS, Rimer BK. Breast cancer risk perceptions and breast cancer worry: what predicts what? J Risk Res. 2005;8:439–52.
40. Humphries G, Rogers S. AFTER and beyond: cancer recurrence fears and test of an intervention in oropharyngeal patients. Soc Sci Dent. 2012;2:29–38.
41. Humphris GM, Ozackinci G. The AFTER intervention: a structured psychological approach to reduce fears of recurrence in patients with head and neck cancer. Br J Health Psychol. 2008;13:223–30.
42. Wells A, Matthews G. Modelling cognition in emotional disorder: the S-REF model. Behav Res Ther. 1996;34:881–8.
43. Cavanagh M, Franklin J. Attention training and hypochondriasis: preliminary results of a controlled treatment trial. World congress of cognitive and behavioral therapy. Vancouver, Canada 2000.
44. Baker P, Beesley H, Dinwoodie R, et al. ‘You’re putting thoughts into my head’: a qualitative study of the readiness of patients with breast, lung or prostate cancer to address emotional needs through the first 18 months after diagnosis. Psycho-Oncology. 2013;22:1402–10.
45. Macleod C, Hagan R. Individual differences in the selective processing of threatening information, and emotional responses to a stressful life event. Behav Res Ther. 1992;30:151–61.
46. Taylor L, Espie C, White C. Attentional bias in people with acute versus persistent insomnia secondary to cancer. Behav Sleep Med. 2003;1:200–12.
47. Chan MW, Ho SM, Tedeschi RG, Leung CW. The valence of attentional bias and cancer-related rumination in posttraumatic stress and posttraumatic growth among women with breast cancer. Psycho-Oncology. 2011;20:544–52.
48. Cook S, Salmon P, Dunn G et al. A prospective study of the association of metacognitive beliefs and processes with persistent emotional distress after diagnosis of cancer. Cogn Ther Res. 2014: 1–10.
49. Cook SA, Salmon P, Dunn G et al. The association of metacognitive beliefs with emotional distress after diagnosis of cancer. Health Psychol. 2014: No Pagination Specified.
50. Stanton AL, Danoff-burg S, Huggins ME. The first year after breast cancer diagnosis: hope and coping strategies as predictors of adjustment. Psycho-Oncology. 2002;11:93–102.
51. Deimling GT, Bowman KF, Sterns S, et al. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psycho-Oncology. 2006;15:306–20.
52. Wells A. Detached mindfulness in cognitive therapy: a metacognitive analysis and ten techniques. J Ration Emot Cogn Behav Ther. 2005;23:337–55.
53. Lengacher C, Jonhson-Mallard V, Post-White J, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology. 2009;18:1261–72.
54. Lengacher CA, Johnson-Mallard V, Barta M, et al. Feasibility of a mindfulness-based stress reduction program for early-stage breast cancer survivors. J Holist Nurs. 2011;29:107–17.
55. Lengacher CA, Shelton MM, Reich RR, et al. Mindfulness based stress reduction (MBSR(BC)) in breast cancer: evaluating fear of recurrence (FOR) as a mediator of psychological and physical symptoms in a randomized control trial (RCT). J Behav Med. 2014;37:185–95.
56. Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44:1–25.
57. Hayes S, Strohsahl K, Wilson K. Acceptance and commitment therapy; an experiential approach to behaviour change. New York: Guildford Press; 2003.
58. Fletcher L, Hayes S. Relational frame theory, acceptance and commitment therapy, and a functional analytic definition of mindfulness. J Ration Emot Cogn Behav Ther. 2005;23:315–36.
59. Thewes B, Brebach R, Dzidowska M, et al. Current approaches to managing fear of cancer recurrence; a descriptive survey of psychosocial and clinical health professionals. Psycho-Oncology. 2014;23:390–6.
60. Feros DL, Lane L, Ciarrochi J, Blackledge JT. Acceptance and commitment therapy (ACT) for improving the lives of cancer patients: a preliminary study. Psychooncology. 2013;22:459–64.
61. Rost AD, Wilson K, Buchanan E, et al. Improving psychological adjustment among late-stage ovarian cancer patients: examining the role of avoidance in treatment. Cogn Behav Pract. 2012;19:508–17.
62. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Ann Behav Med. 1997;19:362–9.
63. Mishel MH. Uncertainty in illness. Image J Nurs Sch. 1988;20:225–32.
64. Butow P, Bell M, Smith A, et al. Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence. BMC Cancer. 2013;13:201.
65. Butow P, Kelly S, Thewes B, et al. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psycho-Oncology. 2015;24:416–23.
66. Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psycho-Oncology. 2013;22:2059–63.
67. Persoskie A, Ferrer RA, Klein WM. Association of cancer worry and perceived risk with doctor avoidance: an analysis of information avoidance in a nationally representative us sample. J Behav Med. 2014;37:977–87.
68. Sharpe L, Thewes B, Butow P. Attentional biases in cancer survivors: directions for future research. Psycho-Oncology. 2015;24:496.
69. Lichtenthal WG, Tuman M, Beard C, et al. Development of attention and interpretation modification for fear of breast cancer recurrence (AIM-FBCR): preliminary findings. Psycho-Oncology. 2013;22:72–3.
70. Smith AB, Thewes B, Turner J et al. Pilot of a theoretically grounded psychologist-delivered intervention for fear of cancer recurrence (Conquer Fear). Psycho-Oncology 2015: n/a-n/a.